)
Johnson Pharmacare (532154) investor relations material
Johnson Pharmacare Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Unaudited financial results for the quarter ended June 30, 2026, were reviewed by the Audit Committee and approved by the Board on August 13, 2026.
Financial highlights
Total income from operations for the quarter was ₹158.10 lakhs, unchanged year-over-year.
Net loss before tax and exceptional items was ₹110.31 lakhs, compared to a net loss of ₹5.34 lakhs in the same quarter last year.
After accounting for exceptional items, net loss before tax was ₹110.31 lakhs, versus ₹5.34 lakhs loss year-over-year.
Earnings per share (basic and diluted) for the quarter stood at ₹(0.02), compared to ₹(0.00) in the same quarter last year.
Key financial ratios and metrics
Paid-up equity share capital remained at ₹5,500.00 lakhs.
EPS (basic and diluted) for the quarter was ₹(0.02), compared to ₹(0.00) in the prior year quarter.
- Working-capital constraints and share-sale losses accompanied a Rs 129.14 lakh FY23 net loss.532154
Q4 22/23 - A small profit returned, but working-capital scarcity kept operations largely dormant.532154
Q4 20/21 - Rs 32.63m revenue and Rs 0.97m profit, but scarce working capital constrained operations.532154
Q4 21/22 - No operations, zero revenue and a Rs 918,050 loss amid working-capital constraints.532154
Q4 19/20 - A smaller loss offered little relief as working-capital scarcity kept operations inactive.532154
Q4 18/19 - Nil operating revenue and working-capital scarcity defined FY2017-18.532154
Q4 17/18 - Inactive operations and working-capital scarcity drove a ₹752,769 FY17 loss.532154
Q4 16/17 - No revenue, a ₹1.26 million loss, and scarce working capital stalled operations.532154
Q4 15/16 - Inactive operations, nil FY15 revenue and a Rs 737,735 net loss amid funding constraints.532154
Q4 14/15 - Revenue reached ₹17.91bn, but losses, cash burn and a debt repayment default persisted.532154
Q4 13/14
Next Johnson Pharmacare earnings date
Next Johnson Pharmacare earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)